Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia

Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia

Background: HIV, heavy drinking, and smoking are all pro-inflammatory and increase risk for coronary heart disease (CHD). Interventions that reduce alcohol use, smoking, or both in HIV-positive people could lower inflammation, CHD and death risk. Varenicline and cytisine are proven therapies for smo...

Full description

Bibliographic Details
Main Authors: Hilary A. Tindle, Matthew S. Freiberg, Natalia Gnatienko, Elena Blokhina, Debbie M. Cheng, Tatiana Yaroslavtseva, Sally Bendiks, Michael Winter, Evgeny Krupitsky, Jeffrey H. Samet
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Contemporary Clinical Trials Communications
Subjects:
Russia
HIV
Alcohol use
Smoking
Varenicline
Cytisine
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420301095

Internet

http://www.sciencedirect.com/science/article/pii/S2451865420301095

Similar Items